112 related articles for article (PubMed ID: 9838903)
1. [Recent advance of prognostic factor in human colorectal cancer].
Itoh F; Yamamoto H; Fukushima H; Matsuno K; Imai K
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2028-35. PubMed ID: 9838903
[TBL] [Abstract][Full Text] [Related]
2. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer.
van Triest B; Pinedo HM; Blaauwgeers JL; van Diest PJ; Schoenmakers PS; Voorn DA; Smid K; Hoekman K; Hoitsma HF; Peters GJ
Clin Cancer Res; 2000 Mar; 6(3):1063-72. PubMed ID: 10741735
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers.
Takeda A; Shimada H; Imaseki H; Okazumi S; Natsume T; Suzuki T; Ochiai T
Oncol Rep; 2000; 7(2):333-8. PubMed ID: 10671682
[TBL] [Abstract][Full Text] [Related]
6. [Recent progress of prognostic factors in renal cell carcinoma].
Shimazui T
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2049-54. PubMed ID: 9838906
[TBL] [Abstract][Full Text] [Related]
7. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the biology of colorectal cancer.
Grogan L; Behan KA; Johnston PG
Histol Histopathol; 1996 Jul; 11(3):807-20. PubMed ID: 8839768
[TBL] [Abstract][Full Text] [Related]
9. [Application of genetic diagnosis for colorectal cancer].
Shimada M
Rinsho Byori; 2001 Dec; 49(12):1237-41. PubMed ID: 11797394
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma.
Ono T; Miki C
Am J Gastroenterol; 2000 Apr; 95(4):1062-7. PubMed ID: 10763960
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic studies of the adenoma-carcinoma sequence.
Fearon ER
Adv Intern Med; 1994; 39():123-47. PubMed ID: 8140953
[TBL] [Abstract][Full Text] [Related]
12. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of angiogenesis in colorectal cancer.
Papamichael D
Anticancer Res; 2001; 21(6B):4349-53. PubMed ID: 11908690
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
15. Prognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy.
Graziano F; Catalano V; Baldelli AM; Cascinu S
Expert Rev Anticancer Ther; 2001 Aug; 1(2):247-57. PubMed ID: 12113030
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
Nakayama Y; Sako T; Shibao K; Okazaki K; Rempo N; Onitsuka K; Minagawa N; Akahane K; Nagashima N; Nagata N; Itoh H
Anticancer Res; 2002; 22(4):2437-42. PubMed ID: 12174940
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
19. Construction of preferential cDNA microarray specialized for human colorectal carcinoma: molecular sketch of colorectal cancer.
Takemasa I; Higuchi H; Yamamoto H; Sekimoto M; Tomita N; Nakamori S; Matoba R; Monden M; Matsubara K
Biochem Biophys Res Commun; 2001 Aug; 285(5):1244-9. PubMed ID: 11478790
[TBL] [Abstract][Full Text] [Related]
20. [Molecular pathology of colorectal cancer].
Bosman FT; Joris F
Rev Med Suisse Romande; 1999 Oct; 119(10):775-82. PubMed ID: 10582488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
